US Stock MarketDetailed Quotes

CLSD Clearside Biomedical

Watchlist

1.390
+0.040+2.96%

Close May 30 16:00 ET

1.360
-0.030-2.16%

Post 16:47 ET

103.88MMarket Cap-2527P/E (TTM)

Clearside Biomedical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-8.80%-7.85M

-35.69%-18.14M

108.83%495K

1.79%-6.08M

1.91%-5.34M

-286.41%-7.22M

-24.52%-13.37M

-210.94%-5.61M

-88.71%-6.19M

21.68%-5.44M

Net income from continuing operations

-26.76%-11.76M

1.40%-32.49M

49.99%-4.83M

-18.40%-9.27M

-16.55%-9.11M

-21.40%-9.28M

-8,862.50%-32.95M

-151.65%-9.66M

-60.16%-7.83M

-28.19%-7.81M

Operating gains losses

--1.5M

----

103.31%33K

----

Depreciation and amortization

86.67%28K

-53.79%67K

-9.09%20K

-58.97%16K

-57.89%16K

-67.39%15K

-18.54%145K

-51.11%22K

-11.36%39K

-13.64%38K

Other non cash items

10.89%2.4M

185.05%9.36M

14.65%2.28M

--2.62M

--2.29M

--2.17M

--3.28M

--1.99M

----

Change In working capital

6.82%-1.08M

-93.59%720K

131.56%2M

32.38%-520K

-59.51%396K

-111.41%-1.16M

173.23%11.24M

105.78%865K

-408.84%-769K

143.86%978K

-Change in receivables

----

-102.11%-220K

----

195.87%10.42M

----

-Change in prepaid assets

368.48%443K

----

-73.52%-911K

121.70%46K

-101.54%-165K

----

-683.58%-525K

69.14%-212K

-Change in payables and accrued expense

-4.03%-1.11M

-11.53%614K

146.01%647K

339.49%752K

-80.29%282K

-55.54%-1.07M

1.91%694K

-45.32%263K

-188.20%-314K

195.15%1.43M

-Change in other working capital

-665.75%-413K

167.21%326K

307.46%546K

-615.71%-361K

128.22%68K

-54.09%73K

102.37%122K

102.66%134K

275.00%70K

-517.95%-241K

Cash from discontinued investing activities

Operating cash flow

-8.80%-7.85M

-35.69%-18.14M

108.83%495K

1.79%-6.08M

1.91%-5.34M

-286.41%-7.22M

-24.52%-13.37M

-210.94%-5.61M

-88.71%-6.19M

21.68%-5.44M

Investing cash flow

Cash flow from continuing investing activities

50.43%-57K

-622.36%-1.78M

-31.87%-120K

-187.10%-445K

-1.1M

-115K

-246K

-91K

-155K

Net PPE purchase and sale

50.43%-57K

-622.36%-1.78M

-31.87%-120K

-187.10%-445K

---1.1M

---115K

---246K

---91K

---155K

--0

Cash from discontinued investing activities

Investing cash flow

50.43%-57K

-622.36%-1.78M

-31.87%-120K

-187.10%-445K

---1.1M

---115K

---246K

---91K

---155K

--0

Financing cash flow

Cash flow from continuing financing activities

4,220.18%14.34M

-98.68%414K

-144.70%-257K

-98.97%317K

450.00%22K

410.77%332K

31.75%31.33M

248.48%575K

1,374.72%30.69M

-99.94%4K

Net common stock issuance

4,750.85%14.31M

194.35%1.67M

31.27%743K

--266K

--362K

--295K

-97.57%566K

18,966.67%566K

--0

Proceeds from stock option exercised by employees

-10.81%33K

-24.03%98K

--0

0.00%51K

150.00%10K

-43.08%37K

-74.15%129K

-94.64%9K

-75.24%51K

-87.88%4K

Net other financing activities

----

-104.41%-1.35M

---1M

--0

----

--30.64M

--0

----

Cash from discontinued financing activities

Financing cash flow

4,220.18%14.34M

-98.68%414K

-144.70%-257K

-98.97%317K

450.00%22K

410.77%332K

31.75%31.33M

248.48%575K

1,374.72%30.69M

-99.94%4K

Net cash flow

Beginning cash position

-40.27%28.92M

57.73%48.42M

-46.21%28.8M

19.91%35.01M

19.60%41.42M

57.73%48.42M

73.94%30.7M

110.15%53.54M

9.44%29.19M

30.65%34.63M

Current changes in cash

191.94%6.44M

-210.02%-19.5M

102.30%118K

-125.48%-6.2M

-17.93%-6.41M

-277.82%-7M

35.81%17.72M

-198.16%-5.12M

2,134.09%24.35M

-3,356.89%-5.44M

End cash Position

-14.64%35.36M

-40.27%28.92M

-46.21%28.8M

19.91%35.01M

19.60%41.42M

57.73%48.42M

110.15%53.54M

9.44%29.19M

Free cash flow

-7.87%-7.91M

-46.29%-19.91M

106.58%375K

-2.82%-6.52M

-18.24%-6.44M

-289.38%-7.33M

-26.81%-13.61M

-212.74%-5.7M

-93.44%-6.34M

21.68%-5.44M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-8.80%-7.85M	-35.69%-18.14M	108.83%495K	1.79%-6.08M	1.91%-5.34M	-286.41%-7.22M	-24.52%-13.37M	-210.94%-5.61M	-88.71%-6.19M	21.68%-5.44M
Net income from continuing operations	-26.76%-11.76M	1.40%-32.49M	49.99%-4.83M	-18.40%-9.27M	-16.55%-9.11M	-21.40%-9.28M	-8,862.50%-32.95M	-151.65%-9.66M	-60.16%-7.83M	-28.19%-7.81M
Operating gains losses	--1.5M	----	----	----	----	----	103.31%33K	----	----	----
Depreciation and amortization	86.67%28K	-53.79%67K	-9.09%20K	-58.97%16K	-57.89%16K	-67.39%15K	-18.54%145K	-51.11%22K	-11.36%39K	-13.64%38K
Other non cash items	10.89%2.4M	185.05%9.36M	14.65%2.28M	--2.62M	--2.29M	--2.17M	--3.28M	--1.99M	----	----
Change In working capital	6.82%-1.08M	-93.59%720K	131.56%2M	32.38%-520K	-59.51%396K	-111.41%-1.16M	173.23%11.24M	105.78%865K	-408.84%-769K	143.86%978K
-Change in receivables	----	-102.11%-220K	----	----	----	----	195.87%10.42M	----	----	----
-Change in prepaid assets	368.48%443K	----	----	-73.52%-911K	121.70%46K	-101.54%-165K	----	----	-683.58%-525K	69.14%-212K
-Change in payables and accrued expense	-4.03%-1.11M	-11.53%614K	146.01%647K	339.49%752K	-80.29%282K	-55.54%-1.07M	1.91%694K	-45.32%263K	-188.20%-314K	195.15%1.43M
-Change in other working capital	-665.75%-413K	167.21%326K	307.46%546K	-615.71%-361K	128.22%68K	-54.09%73K	102.37%122K	102.66%134K	275.00%70K	-517.95%-241K
Cash from discontinued investing activities
Operating cash flow	-8.80%-7.85M	-35.69%-18.14M	108.83%495K	1.79%-6.08M	1.91%-5.34M	-286.41%-7.22M	-24.52%-13.37M	-210.94%-5.61M	-88.71%-6.19M	21.68%-5.44M
Investing cash flow
Cash flow from continuing investing activities	50.43%-57K	-622.36%-1.78M	-31.87%-120K	-187.10%-445K	-1.1M	-115K	-246K	-91K	-155K	0
Net PPE purchase and sale	50.43%-57K	-622.36%-1.78M	-31.87%-120K	-187.10%-445K	---1.1M	---115K	---246K	---91K	---155K	--0
Cash from discontinued investing activities
Investing cash flow	50.43%-57K	-622.36%-1.78M	-31.87%-120K	-187.10%-445K	---1.1M	---115K	---246K	---91K	---155K	--0
Financing cash flow
Cash flow from continuing financing activities	4,220.18%14.34M	-98.68%414K	-144.70%-257K	-98.97%317K	450.00%22K	410.77%332K	31.75%31.33M	248.48%575K	1,374.72%30.69M	-99.94%4K
Net common stock issuance	4,750.85%14.31M	194.35%1.67M	31.27%743K	--266K	--362K	--295K	-97.57%566K	18,966.67%566K	--0	--0
Proceeds from stock option exercised by employees	-10.81%33K	-24.03%98K	--0	0.00%51K	150.00%10K	-43.08%37K	-74.15%129K	-94.64%9K	-75.24%51K	-87.88%4K
Net other financing activities	----	-104.41%-1.35M	---1M	--0	----	----	--30.64M	--0	----	----
Cash from discontinued financing activities
Financing cash flow	4,220.18%14.34M	-98.68%414K	-144.70%-257K	-98.97%317K	450.00%22K	410.77%332K	31.75%31.33M	248.48%575K	1,374.72%30.69M	-99.94%4K
Net cash flow
Beginning cash position	-40.27%28.92M	57.73%48.42M	-46.21%28.8M	19.91%35.01M	19.60%41.42M	57.73%48.42M	73.94%30.7M	110.15%53.54M	9.44%29.19M	30.65%34.63M
Current changes in cash	191.94%6.44M	-210.02%-19.5M	102.30%118K	-125.48%-6.2M	-17.93%-6.41M	-277.82%-7M	35.81%17.72M	-198.16%-5.12M	2,134.09%24.35M	-3,356.89%-5.44M
End cash Position	-14.64%35.36M	-40.27%28.92M	-40.27%28.92M	-46.21%28.8M	19.91%35.01M	19.60%41.42M	57.73%48.42M	57.73%48.42M	110.15%53.54M	9.44%29.19M
Free cash flow	-7.87%-7.91M	-46.29%-19.91M	106.58%375K	-2.82%-6.52M	-18.24%-6.44M	-289.38%-7.33M	-26.81%-13.61M	-212.74%-5.7M	-93.44%-6.34M	21.68%-5.44M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall